New tetanus shot under study in 10,000 people

NCT ID NCT07107932

Recruiting now Prevention Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This large real-world study is testing an injection called siltartoxatug (Sintetol®) to prevent tetanus in people who have been injured. Researchers will follow 10,000 participants for 90 days to see if the shot prevents tetanus and to track any side effects. The goal is to learn how well this treatment works in everyday medical settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: siltartoxatug injection (Sintetol®)
What this could lead to: If successful, this could confirm siltartoxatug as a safe and effective way to prevent tetanus after an injury, potentially replacing current treatments.
What could go wrong: This is an observational registry, not a controlled trial, so results may be less definitive. Side effects are possible, and the study does not compare siltartoxatug to other treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TETANUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

tetanus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TETANUS

Contacts and locations

Locations

Shaoxing Central Hospital
RECRUITING

Shaoxing, Zhejiang, 312030, China
The Second Affiliated Hospital of Shantou University
NOT_YET_RECRUITING

Shantou, Guangdong, 515041, China
Xiangyun County People's Hospital
NOT_YET_RECRUITING

Xiangyun, Yunnan, 672100, China
Zhoushan Putuo District People's Hospital
NOT_YET_RECRUITING

Zhoushan, Zhejiang, 316100, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.